Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection

International Journal of Colorectal Disease

Volumn 18, Issue 2, 2003, Pages 148-152

  Bombski, G ^a   Gasiorowska, A ^b   Orszulak Michalak, D ^b   Neneman, B ^a   Kotynia, J ^b   Strzelczyk, J ^b   Janiak, A ^b   Malecka Panas, Ewuncia ^b  

^a Regional Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cancer antigen 19 9; Carcinoembryonic antigen; Colorectal cancer; Gastrin

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GASTRIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GASTRIN BLOOD LEVEL; GASTROINTESTINAL MUCOSA; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; BLOOD; COLORECTAL TUMOR; HELICOBACTER INFECTION; MIDDLE AGED;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOIMMUNOASSAY;

EID: 0037714351     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-002-0420-9     Document Type: Article

References (53)

1. Smith AM, Watson SA (2000) Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 47:820-824
2. Singh P, Owila A, Varro A, Dai B, Rajaraman S, Wood T (1996) Gastrin gene expression is required for the proliferation and tumorgenicity of human colon cancer cells. Cancer Res 56:4111-4115
3. Guo YS, Baijal M, Jin GF, Thompson JC, Townsend CM, Singh P (1990) Growth-promoting effects of gastrin on mouse colon cancer cells in vitro: absence of autocrine effects. In Vitro Cell Dev Biol 26:871-877
4. Boland CR (1991) Gastrin and colorectal neoplasia - chicken or egg or both? J Clin Gastroenterol 13:497-499
5. Elewaut A, Vanderstraeten E (1995) Serum gastrin levels and colorectal neoplasia. Gastroenterology 108:618-419
6. Saurin JC, Rouault JP, Abello J, Berger F, Remy L, Chayvialle JA (1999) High gastrin releasing peptide receptor mRNA level is related to tumor dedifferentiation and lymphatic vessel invasion in human colon cancer. Eur J Cancer 35:125-132
7. Singh P, Xu Z, Dai B, Rajaraman S, Rubin N, Dhruva B (1994) Incomplete processing of progastrin expressed by human colon cancer cells: role of non-carboxyamidated gastrins. Am J Physiol 266:G459-G468
8. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, Karczewska E, Bielanski W, Marlicz K, Starzynska T, Lawniczak M, Hahn EG (2001) Helicobacter infecfion, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis 16:202-210
9. Renga M, Brandi G, Paganelli GM, Calabrese C, Papa S, Tosti A, Tomassetti P, Miglioli M, Biasco G (1997) Rectal cell proliferation and colon cancer risk in patients with hypergastrinemia. Gut 41:330-332
10. Malecka-Panas E, Tureaud J, Majumdar APN (1996) Gastrin activates tyrosine kinase (Tyr-k) and phospholipase C (PLC) in isolated rat colonocytes. Acta Biochim Pol 43:539-546
11. Malecka-Panas E, Fligiel J, Majumdar APN (1997) Differential responsiveness of proximal and distal colonic mucosa to gastrin. Peptides 18:559-565
12. Karlin DA, Mc Bath M, Jones RD, Elwyn KE, Romsdahl MM (1985) Hypergastrinemia and colorectal carcinogenesis in the rat. Cancer Lett 29:73-78
13. Watson SA, Smith AM (2001) Hypergastrinemia promotes adenoma progression in the APC (Min+/-) mouse model of familial adenomatous polyposis. Cancer Res 61:625-631
14. Begos DG, Modlin IM (1994) Gastrin and colorectal cancer. Clarifying the controversy. J Clin Gastroenterol 18:189-193
15. Garnett WR (1998) Considerations for long-term use of proton-pump inhibitors. Am J Health Syst Pharm 55:2286-2279
16. Wong K, Beardshall K, Waters CM, Waters CM, Calam GJ, Poston GJ (1991) Postprandial hypergastrinemia in patients with colorectal cancer. Gut 32:1352-1354
17. Charnley RM, Thomas WM, Stanley J, Morris DL (1992) Serum gastrin concentrations in colorectal cancer patients. Ann R Coll Surg Engl 74:138-140
18. Mihas AA, Maliakkal RJ, Shueke M, Achord JL (1995) Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study. Res Commun Mol Pathol Pharmacol 90:301-304
19. Yapp RG, Modlin IM, Kumar RR, Binder H, Dubrow R (1992) Gastrin and colorectal cancer: evidence against an association. Dig Dis Sci 37:481-484
20. Penman ID, el-Omar E, Ardill JE, McGregor JR, Galloway D, O'Dwyer PJ, McColl KE (1994) Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology 106:1263-1270
21. Orbuch M, Venzon DJ, Lubensky IA, Weber HC, Gibril F, Jensen RT (1996) Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. Dig Dis Sci 41:604-613
22. Seitz JF, Giovannini M, Monges G, Sauvan R, Wartelle G, Martin P (1992) Serum gastrin levels in colorectal cancers. Evolution after treatment. Gastroenterol Clin Biol 16:385-387
23. Kleist S von, Hesse Y, Kananeeh H (1996) Comparative evaluation of tumor markers, Ca 242, CA 19-9, TPA and CEA in carcinomas of the colon. Anticancer Res 16:2325-2331
24. Lindmark G, Bergstrom R, Pahlman L, Glimelius B (1995) The association of preoperative serum tumour markers with Dukes stage and survival in colorectal cancer. Br J Cancer 71:1090-1094
25. Nahachai V, Walker K, Sevelius H, Thompson ABR (1987) Antisecretory and serum gastrin lowering effect of endoprostil in patients with duodenal ulcer disease. Proc Natl Acad Sci USA 84:7188-7192
26. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia F (1993) Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth and gastritis. Gastroenterology 104:1356-1370
27. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF (1993) Pernicious anemia and subsequent cancer. Cancer 71:745-750
28. Peach HG, Barnett NE (2000) Determinants of basal plasma gastrin levels in the general population. J Gastroenterol Hepatol 15:1267-1271
29. Jass JR, Sobin LH (1989) Histological typing of intestinal tumours (World Health Organization). Springer, Berlin Heidelberg New York
30. Wu J, Rao GN, Dai B, Singh P (2000) Autocrine gastrins in colon cancer cells up-regulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-3. J Biol Chem 275:32491-32498
31. Smith AM, Watson SA, Caplin M, Clarke P, Griffin N, Varro A, Hardcastle JD (1998) Gastric carcinoid expresses the gastrin autocrine pathway. Br J Surg 85:1285-1289
32. Hollande F, Imdahl A, Mantamadiotis T (1997) Glycine-extended gastrin acts as an autocrine growth factor in a non-transformed colon cell line. Gastroenterology 113:1576-1588
33. Hoosein NM, Kiener PA, Curry RC, Brattain MG (1990) Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 186:15-21
34. Rehfeld JF (1995) Gastrin and colorectal cancer: a never-ending dispute? Gastroenterology 108:1307-1310
35. Watson SA, Durrant LG, Morris DL (1989) Gastrin: growth and enhancing effects on human gastric and colonic tumor cells. Br J Cancer 59:554-558
36. Sirinek KR, Levine BA, Moyer MP (1985) Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg 149:35-39
37. Kermorgant S, Lehy T (2001) Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem Biophys Res Commun 285:136-141
38. Ekundayo AA, Lee CY, Goodlad RA (1995) Gastrin and growth of the gastrointestinal tract. Gut 36:203-208
39. Singh P, Walker JP, Townsend CM, Thompson JC (1986) Role of gastrin and gastrin receptors on the growth of transplantable mouse colon carcinoma (MC-26) in BALB/c mice. Cancer Res 46:1612-1616
40. Smith JP, Solomon TE (1988) Effects of gastrin, proglumide and somatostatin on growth of human colon cancer. Gastroenterology 95:1541-1548
41. Smith JP, Solomon TE, Wood JG (1989) Elevated gastrin levels in patients with colon carcinomas or adenomatous polyps. Dig Dis Sci 34:171-174
42. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A (1995) Expression, processing and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 109:1142-1153
43. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J (1998) Gastrin and colorectal cancer: a prospective study. Gastroenterology 115:275-280
44. Fontanesi BV, Boris B, Delcio M, Manoukian FN (1997) Gastrin levels in patients with colorectal cancer. Hepatogastroenterology 44:1082-1084
45. Kikendall JW, Glass AR, Sobin LH, Bowen PE (1992) Serum gastrin is not higher in subjects with colonic neoplasia. Am J Gastroenterol 87:1394-1397
46. Vanderstraeten EF, De Vos MM, Versieck JM, Elewaut AP (1995) Serum gastrin levels and colorectal cancer. Dis Colon Rectum 38:172-176
47. Charnley RM, Thomas WM, Stanley J, Moris DL (1992) Serum gastrin concentrations in colorectal cancers patients. Ann R Coll Surg Engl 74:138-140
48. Lamberts R, Wartenberg T, Creutzfeldt W (1999) Role of circulating gastrin in colorectal adenomas and carcinomas. Digestion 60:101-109
49. Upp JR, Singh P, Townsend CM, Thompson JC (1989) Clinical significance of gastrin receptors in human colon cancers. Cancer Res 49:488-492
50. Kameyama M, Fukuda I, Imaoka S, Nakamori S, Iwanaga T (1993) Level of serum gastrin as a predictor of liver metastasis from colorectal cancer. Dis Colon Rectum 36:497-500
51. Verdi CJ, Ahmann FR, Schifman RB, Elvick AL, Ahmann ME, Marx PC (1993) Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma. Cancer 71:3625-3632
52. Filella X, Molina R, Bedini JL, Jo J, Joseph J, Ballesta AM (1990) Clinical usefulness of CEA as tumor marker in patients with colorectal cancer. J Nucl Med Allied Sci 34:107-110
53. Kievit J, Van de Verde CJH (1990) Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. Cancer 65:2580-2587